VisualAbstract BNT162b2 mRNA vaccine shows benefit against
Vaccine Effectiveness Of The Bnt162B2 Mrna Covid-19 Vaccine Against Rt-Pcr Confirmed Sars-Cov-2 Infections. Thompson mg, burgess jl, naleway al, tyner hl, yoon sk, meece j, et al. The cohort created by the moscow health department included more than 300,000 infected people who sought medical care in june and july 2021.
In sensitivity analyses, vaccine effectiveness estimates using ≥21 d after the first dose and ≥14 d after the second dose were found to. Vaccine effectiveness was 87.4% (95% ci: Thompson mg, burgess jl, naleway al, et al. Patients were excluded based on the following conditions: The cohort created by the moscow health department included more than 300,000 infected people who sought medical care in june and july 2021. In model 2, we conducted a separate analysis of households comprised of only adults with the same vaccination status. None of the vaccinated patients required intensive care unit admission or died. In singapore, two mrna vaccines ( 20 rows the bnt162b2 vaccine was effective against infection and disease in the population of qatar, despite the b.1.1.7 and b.1.351 variants being predominant within the country; Effectiveness was estimated to be 87.0% (95% ci, 81.8 to 90.7) against the b.1.1.7 variant and 72.1% (95% ci, 66.4 to 76.8) against the b.1.351 variant, findings that confirm the results reported.
In sensitivity analyses, vaccine effectiveness estimates using ≥21 d after the first dose and ≥14 d after the second dose were found to. None of the vaccinated patients required intensive care unit admission or died. Thompson mg, burgess jl, naleway al, tyner hl, yoon sk, meece j, et al. In sensitivity analyses, vaccine effectiveness estimates using ≥21 d after the first dose and ≥14 d after the second dose were found to. 46.0, 97.1) for any documented infection and 91.7% (95% ci: Results beyond 7 days after the. The cohort created by the moscow health department included more than 300,000 infected people who sought medical care in june and july 2021. In singapore, two mrna vaccines ( 1) receipt of only 1. Effectiveness was estimated to be 87.0% (95% ci, 81.8 to 90.7) against the b.1.1.7 variant and 72.1% (95% ci, 66.4 to 76.8) against the b.1.351 variant, findings that confirm the results reported. In model 2, we conducted a separate analysis of households comprised of only adults with the same vaccination status.
